Demars Financial Group, LLC Merck & Co., Inc. Transaction History

Demars Financial Group, LLC

  • $214 Million
  • Q3 2024

A detailed history of Demars Financial Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Demars Financial Group, LLC holds 7,402 shares of MRK stock, worth $736,128. This represents 0.39% of its overall portfolio holdings.

Number of Shares
7,402
Previous 7,421 0.26%
Holding current value
$736,128
Previous $918,000 8.5%
% of portfolio
0.39%
Previous 0.45%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$111.15 - $128.97 $2,111 - $2,450
-19 Reduced 0.26%
7,402 $840,000
Q2 2024

Jul 19, 2024
SELL
$123.8 - $132.96 $25,750 - $27,655
-208 Reduced 2.73%
7,421 $918,000
Q1 2024

Apr 24, 2024
SELL
$113.24 - $131.95 $608,438 - $708,967
-5,373 Reduced 41.32%
7,629 $1.01 Million
Q4 2023

Feb 01, 2024
SELL
$100.18 - $109.02 $3.43 Million - $3.73 Million
-34,212 Reduced 72.46%
13,002 $1.42 Million
Q3 2023

Oct 18, 2023
SELL
$102.95 - $114.33 $83,595 - $92,835
-812 Reduced 1.69%
47,214 $4.86 Million
Q2 2023

Jul 20, 2023
SELL
$108.61 - $118.38 $148,144 - $161,470
-1,364 Reduced 2.76%
48,026 $5.54 Million
Q1 2023

Apr 20, 2023
SELL
$102.94 - $114.86 $139,174 - $155,290
-1,352 Reduced 2.66%
49,390 $5.25 Million
Q4 2022

Feb 13, 2023
SELL
$87.44 - $112.11 $658,423 - $844,188
-7,530 Reduced 12.92%
50,742 $5.63 Million
Q3 2022

Oct 21, 2022
SELL
$84.53 - $94.96 $273,285 - $307,005
-3,233 Reduced 5.26%
58,272 $5.02 Million
Q2 2022

Jul 22, 2022
BUY
$83.49 - $94.64 $4.19 Million - $4.75 Million
50,199 Added 444.0%
61,505 $5.61 Million
Q1 2022

Apr 27, 2022
BUY
$73.51 - $82.4 $9,997 - $11,206
136 Added 1.22%
11,306 $928,000
Q4 2021

Feb 02, 2022
BUY
$72.28 - $90.54 $95,698 - $119,874
1,324 Added 13.45%
11,170 $856,000
Q3 2021

Oct 15, 2021
BUY
$71.68 - $78.83 $262,277 - $288,438
3,659 Added 59.14%
9,846 $740,000
Q2 2021

Jul 16, 2021
BUY
$70.31 - $77.77 $136,542 - $151,029
1,942 Added 45.75%
6,187 $481,000
Q1 2021

Apr 13, 2021
SELL
$68.86 - $81.11 $55,088 - $64,888
-800 Reduced 15.86%
4,245 $327,000
Q4 2020

Jan 25, 2021
SELL
$71.77 - $79.65 $2.69 Million - $2.99 Million
-37,534 Reduced 88.15%
5,045 $413,000
Q3 2020

Oct 21, 2020
BUY
$73.18 - $82.95 $37,760 - $42,802
516 Added 1.23%
42,579 $3.53 Million
Q2 2020

Sep 15, 2020
SELL
$70.42 - $80.13 $26.7 Million - $30.3 Million
-378,569 Reduced 90.0%
42,063 $3.25 Million
Q2 2020

Aug 11, 2020
BUY
$70.42 - $80.13 $26.8 Million - $30.5 Million
380,701 Added 953.4%
420,632 $3.25 Million
Q1 2020

Apr 27, 2020
BUY
$63.36 - $87.82 $63,550 - $88,083
1,003 Added 2.58%
39,931 $3.07 Million
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $3.02 Million - $3.41 Million
38,928 New
38,928 $3.54 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Demars Financial Group, LLC Portfolio

Follow Demars Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Demars Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Demars Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email